Comments

Neurocrine Biosciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Neurocrine Biosciences (NBIX) operate in?

Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NBIXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$115.60

3.683.29%

At close: -

$115.60

0.000.00%

After Hours: 4:38 PM EDT

Neurocrine Biosciences (NBIX) Forecast

News Earnings Neurocrine Biosciences (NBIX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Neurocrine Biosciences Stock Price, Quotes and Forecasts | NASDAQ:NBIX | Benzinga

Explore Neurocrine Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NBIX.

Open	$112.65
Close	$115.60
Volume / Avg.	1.18M / 1.29M
Day Range	$112.59 - $115.76
52 Wk Range	105.18 - 157.98
Market Cap	$11.53B
P/E Ratio	34.04
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	3.79%
Days to Cover	2.55

Recent News

Estee Lauder, Moderna And PayPal Are Among Top 10 Large Cap Losers Last Week (Feb 3-Feb 7): Are The Others In Your Portfolio?

Skyworks Solutions, Estee Lauder, Venture Global, Neurocrine Biosciences, Moderna, Illumina, IDEX Corporation, PTC Inc, PayPal Holdings, Skechers U.S.A. and Avantor were worst performers, fell up to 25%.

Lekha Gupta

Why Is Neurocrine Biosciences Stock Trading Lower On Friday?

Neurocrine Biosciences Q4 earnings topped forecasts, but revenue slightly missed. Analysts see Ingrezza's long-term growth despite near-term challenges.

Vandana Singh

Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan Rights

Neurocrine Biosciences advances Phase 3 plans for osavampator after achieving Phase 2 success in major depressive disorder, amending its Takeda deal.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$112.65
Close	$115.60
Volume / Avg.	1.18M / 1.29M
Day Range	$112.59 - $115.76
52 Wk Range	105.18 - 157.98
Market Cap	$11.53B
P/E Ratio	34.04
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	3.79%
Days to Cover	2.55

About Neurocrine Biosciences, Inc.

Sector

Health Care

Industry

Biotechnology

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Neurocrine Biosciences (NBIX) stock?

You can purchase shares of Neurocrine Biosciences (NASDAQ:NBIX) through any online brokerage.

View our list of the best stock brokerages

Who are Neurocrine Biosciences (NBIX) competitors?

Other companies in Neurocrine Biosciences’s space includes: BeiGene (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Roivant Sciences (NASDAQ:ROIV), Amgen (NASDAQ:AMGN) and United Therapeutics (NASDAQ:UTHR).

What is the forecast, or price target, for Neurocrine Biosciences (NBIX) stock?

Neurocrine Biosciences has a consensus price target of $162.71.

What is the current price for Neurocrine Biosciences (NBIX)?

The stock price for Neurocrine Biosciences (NASDAQ: NBIX) is $115.6 last updated March 24, 2025 at 4:38 PM EDT.

Does Neurocrine Biosciences (NBIX) pay a dividend?

There are no upcoming dividends for Neurocrine Biosciences.

When is Neurocrine Biosciences (NASDAQ:NBIX) reporting earnings?

Neurocrine Biosciences’s Q1 earnings are confirmed for Wednesday, April 30, 2025.

Is Neurocrine Biosciences (NBIX) going to split?

There is no upcoming split for Neurocrine Biosciences.

What sector and industry does Neurocrine Biosciences (NBIX) operate in?

Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.